Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Journal of Clinical Pharmacology
|
June 1, 1991
Evaluation of labetalol in elderly patients with essential hypertension
T D Giles, M Weber, D W Bartels, et al.
American Journal of Human Genetics
|
June 1, 1996
A mutation causing Alport syndrome with tardive hearing loss is common in the western United States
D F Barker, C J Pruchno, X Jiang, et al.
The Journal of Clinical Investigation
|
September 1, 1993
X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis
D G Bichet, M F Arthus, M Lonergan, et al.
British Journal of Urology
|
December 1, 1987
Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases
L R Baker, W J Mallinson, M C Gregory, et al.
Science (New York, N.Y.)
|
June 8, 1990
Identification of mutations in the COL4A5 collagen gene in Alport syndrome
D F Barker, S L Hostikka, J Zhou, et al.
Human Genetics
|
December 1, 1991
High-density genetic and physical mapping of DNA markers near the X-linked Alport syndrome locus: definition and use of flanking polymorphic markers
D F Barker, P R Fain, D E Goldgar, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
September 28, 1998
Expression of mRNA for type IV collagen alpha1, alpha5 and alpha6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome
S Sasaki, B Zhou, W W Fan, et al.
American Journal of Human Genetics
|
October 9, 2001
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes
K E Heath, A Campos-Barros, A Toren, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Journal of Clinical Pharmacology
|
June 1, 1991
Evaluation of labetalol in elderly patients with essential hypertension
T D Giles, M Weber, D W Bartels, et al.
American Journal of Human Genetics
|
June 1, 1996
A mutation causing Alport syndrome with tardive hearing loss is common in the western United States
D F Barker, C J Pruchno, X Jiang, et al.
The Journal of Clinical Investigation
|
September 1, 1993
X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis
D G Bichet, M F Arthus, M Lonergan, et al.
British Journal of Urology
|
December 1, 1987
Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases
L R Baker, W J Mallinson, M C Gregory, et al.
Science (New York, N.Y.)
|
June 8, 1990
Identification of mutations in the COL4A5 collagen gene in Alport syndrome
D F Barker, S L Hostikka, J Zhou, et al.
Human Genetics
|
December 1, 1991
High-density genetic and physical mapping of DNA markers near the X-linked Alport syndrome locus: definition and use of flanking polymorphic markers
D F Barker, P R Fain, D E Goldgar, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
September 28, 1998
Expression of mRNA for type IV collagen alpha1, alpha5 and alpha6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome
S Sasaki, B Zhou, W W Fan, et al.
American Journal of Human Genetics
|
October 9, 2001
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes
K E Heath, A Campos-Barros, A Toren, et al.
Page
of 6